MIchael Fumento brings all the points about the fake "no embyros were killed here, so buy our stock" incident together in one handy place:

The ACT researchers’ letter left the embryos’ fate ambiguous, but an accompanying figure showed a photo of a biopsied embryo at a later stage of development – one Lanza’s embryos never reached. A longer Nature press release accompanying the article explicitly stated only one cell was removed and the embryos survived. (It has since been corrected, and Lanza’s letter will be also.) ACT’s press release declared repeatedly that the embryos survived, with CEO William Caldwell IV celebrating “Our ability to create human embryonic cell lines and therapies without harming the embryo . . . ”

Lanza also clearly lied in an audio interview for Nature, saying “in this instance there is no harm to the embryo that we’re biopsying.” So did Caldwell, telling PBS’s NewsHour “In this case, we do not destroy the embryo” and therefore it was “a major scientific breakthrough.”

Lo! After steadily declining for six months, ACT stock suddenly shot up 500% and both Lanza and Caldwell, already quite wealthy, became quite wealthier. Then just two days after the Nature report, ACT announced it had received commitments to raise about $13.5 million.

But then along came busy-body Richard Doerflinger of the United States Conference of Catholic Bishops. In a detailed e-mail (later posted online), he showed step-by-step that Lanza did nothing new besides perhaps reaching new heights in scientific dishonesty.

To their credit, many in the media have admitted ACT and Nature took them for a ride had taken them for a ride.

But ACT propagandist, er, uh, ethicist Ronald Green leapt to the company’s defense. “The approach does not harm embryos; the experiment did,” Green insisted. (Right. And “I didn’t kill the victim;” the shooter said, “the bullets did!”) An utterly unrepentant Lanza tossed off the backlash criticism as merely indicative of how politicized stem cell research has become. Now there’s something he knows about.

Lanza has always been more salesman than scientist, constantly inveighing against the federal funding restrictions that restrict the growth of his bank account. Yet the media treat him as an impartial source on all things stem cell. Welcome to the world of ESC “science” – about 10% research and 90% hype.